but, scoutmaster, that can only be half the story.IF FDA...

but, scoutmaster, that can only be half the story.

IF FDA approval had come through, then Dr Reddy's would not be able to sit on it without releasing. Even if there is no need for a trading halt in advance, they can't just hold off on making a significant announcement.

What would make sense to me is that the latest communication with the FDA has made it clear that approval is very very close.

ACL has therefore thought it prudent to go into a trading halt in anticipation, but Dr R's has not felt such a need due to relative company size etc etc.

This makes sense to me as a possibility. Before ACR got its approval last year, it seemed that most of the melbourne biotech community knew a couple of days out that approval was expected "this week".